Daiwa Securities Group Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
-16.7%
2040.0%0.00%
Q2 2023$6
+20.0%
2040.0%0.00%
Q1 2023$5
-16.7%
2040.0%0.00%
Q4 2022$6
-99.9%
2040.0%0.00%
Q3 2022$6,000
+20.0%
2040.0%0.00%
Q2 2022$5,0000.0%204
+29.1%
0.00%
Q1 2022$5,0000.0%1580.0%0.00%
Q4 2021$5,000
-44.4%
158
-21.8%
0.00%
Q3 2021$9,000
+28.6%
202
+65.6%
0.00%
Q2 2021$7,0000.0%122
-11.6%
0.00%
Q1 2021$7,000
+16.7%
138
+6.2%
0.00%
Q4 2020$6,000
-57.1%
130
-66.3%
0.00%
Q3 2020$14,0000.0%3860.0%0.00%
Q2 2020$14,0000.0%3860.0%0.00%
Q1 2020$14,000
-22.2%
3860.0%0.00%
Q4 2019$18,000
+50.0%
386
+4.0%
0.00%
Q3 2019$12,000
-36.8%
3710.0%0.00%
Q2 2019$19,000
-24.0%
3710.0%0.00%
Q1 2019$25,000
+78.6%
371
+18.2%
0.00%
Q4 2018$14,000
-41.7%
3140.0%0.00%
Q3 2018$24,000
-7.7%
3140.0%0.00%
Q2 2018$26,0000.0%3140.0%0.00%
Q1 2018$26,0003140.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders